Vanguard Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $101K | Sell |
|
|||||
|
2022
Q4 | $328K | Buy |
|
|||||
|
2022
Q3 | $644K | Buy |
|
|||||
|
2022
Q2 | $2.11M | Buy |
|
|||||
|
2022
Q1 | $3.86M | Sell |
|
|||||
|
2021
Q4 | $7.61M | Buy |
|
|||||
|
2021
Q3 | $10.8M | Buy |
|
|||||
|
2021
Q2 | $10.3M | Buy |
|
|||||
|
2021
Q1 | $6.19M | Buy |
|
|||||
|
2020
Q4 | $6.06M | Buy |
|